MAFCarfilzomib Infusion 30 mg
1) Carfilzomib in combination with lenalidomide or thalidomide or cyclophosphamide, plus dexamethasone, for patients with multiple myeloma who have received at least one prior therapy. Treatment with carfilzomib should be stopped after 18 cycles, or earlier if disease progresses.
2) Carfilzomib in combination with dexamethasone for patients with multiple myeloma who have received at least one prior therapy.